FdaApplication

BLA 761436

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBiocon Biologics Inc.
application_typeBLA
approval_date2025-09-16

Products (2)

ProductActive ingredientStrengthDosage form
BOSAYADENOSUMAB-KYQQ60MG/MLInjection
AUKELSODENOSUMAB-KYQQ120MG/1.7ML (70MG/ML)Injection

2 products